Additionally, basic experiments in vivo and in vitro are also recommended to verify the mechanistic pathways of COX5A, NDUFAB1, SDHB, UQCRC2, and UQCRFS1 in the pathogenesis of AD, which likely provide a substantial foundation for clinically targeted therapy. The gene discussed is NDUFAB1; the disease is Alzheimer disease.